Advertisement

Advertisement

HK:2105 Stock Latest News

Laekna Sets 2026 AGM to Approve 2025 Results and Share Issuance Mandate

Company AnnouncementsLaekna Sets 2026 AGM to Approve 2025 Results and Share Issuance Mandate

Laekna grants 15.3 million RSUs under 2024 share award scheme

PremiumCompany Announcements

Laekna grants 15.3 million RSUs under 2024 share award scheme

16d ago

Laekna’s Breast Cancer Drug LAE002 Hits Phase III PFS Goal, NDA in China Planned

PremiumCompany Announcements

Laekna’s Breast Cancer Drug LAE002 Hits Phase III PFS Goal, NDA in China Planned

1M ago

Laekna Advances Obesity Candidate LAE102 With Positive Phase I Data

PremiumCompany Announcements

Laekna Advances Obesity Candidate LAE102 With Positive Phase I Data

2M ago

Laekna Announces Positive Phase I Results for Obesity-Targeted Antibody LAE102

PremiumCompany Announcements

Laekna Announces Positive Phase I Results for Obesity-Targeted Antibody LAE102

3M ago

Laekna Sets March 2026 Board Meeting to Approve 2025 Annual Results

PremiumCompany AnnouncementsLaekna Sets March 2026 Board Meeting to Approve 2025 Annual Results

3M ago

Laekna Wins FDA Acceptance of IND for New PI3Kα Inhibitor LAE118

Company Announcements

Laekna Wins FDA Acceptance of IND for New PI3Kα Inhibitor LAE118

4M ago

Laekna Doses First Subject in Phase I Trial of Metabolic Drug Candidate LAE103

Company Announcements

Laekna Doses First Subject in Phase I Trial of Metabolic Drug Candidate LAE103

5M ago

Laekna Doses First Patient in Phase I Multiple-Dose Expansion Study of Obesity Drug LAE102

PremiumCompany Announcements

Laekna Doses First Patient in Phase I Multiple-Dose Expansion Study of Obesity Drug LAE102

5M ago

Laekna Completes Enrollment for Phase III Breast Cancer Trial

PremiumCompany Announcements

Laekna Completes Enrollment for Phase III Breast Cancer Trial

5M ago

Laekna, Inc. Updates Nomination and Governance Committee

PremiumCompany Announcements

Laekna, Inc. Updates Nomination and Governance Committee

5M ago

Laekna, Inc. Announces Board of Directors and Committee Roles

PremiumCompany Announcements

Laekna, Inc. Announces Board of Directors and Committee Roles

5M ago

Laekna, Inc. Updates Governance Committee Terms

PremiumCompany AnnouncementsLaekna, Inc. Updates Governance Committee Terms

5M ago

Laekna, Inc. Partners with Qilu Pharma for Exclusive Licensing of LAE002 in China

Company Announcements

Laekna, Inc. Partners with Qilu Pharma for Exclusive Licensing of LAE002 in China

6M ago

Laekna, Inc. Advances Breast Cancer Treatment with Promising Clinical Study

Company Announcements

Laekna, Inc. Advances Breast Cancer Treatment with Promising Clinical Study

7M ago

Laekna, Inc. Advances Obesity Treatment with LAE102 Study

PremiumCompany Announcements

Laekna, Inc. Advances Obesity Treatment with LAE102 Study

7M ago

Laekna, Inc. Reports Positive Phase I Results for Obesity Treatment

PremiumCompany Announcements

Laekna, Inc. Reports Positive Phase I Results for Obesity Treatment

8M ago

Laekna, Inc. Completes Successful Share Placement to Boost R&D

PremiumCompany Announcements

Laekna, Inc. Completes Successful Share Placement to Boost R&D

8M ago

Laekna, Inc. Advances Obesity Treatment with Promising Clinical Trial Results

PremiumCompany Announcements

Laekna, Inc. Advances Obesity Treatment with Promising Clinical Trial Results

9M ago

Laekna, Inc. Secures FDA Approval for New Metabolic Disease Therapy

PremiumCompany AnnouncementsLaekna, Inc. Secures FDA Approval for New Metabolic Disease Therapy

10M ago

Laekna, Inc. Schedules Board Meeting to Review Interim Results

Company Announcements

Laekna, Inc. Schedules Board Meeting to Review Interim Results

10M ago

Laekna, Inc. Advances LAE103 with FDA Application

Company Announcements

Laekna, Inc. Advances LAE103 with FDA Application

11M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >